Effect of antioxidants on captopril floating matrices

Pharmaceutical Development and Technology

Volumn 15, Issue 3, 2010, Pages 230-240

  Jiménez Martnez, Inéz ^a   Domnguez Ramrez, Adriana Miriam ^a   Villafuerte Robles, Leopoldo ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Antioxidants; Captopril floating tablets; Compaction pressure; Hydration kinetics; Hydroxypropyl methylcellulose

Indexed keywords

ASCORBIC ACID; BICARBONATE; CAPTOPRIL; CARBON DIOXIDE; HYDROXYPROPYLMETHYLCELLULOSE;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSPORT; HYDRATION; MATRIX TABLET; MOLECULAR WEIGHT; POROSITY; PRIORITY JOURNAL; TABLET COMPRESSION;

ANTIOXIDANTS; CAPTOPRIL; CHEMISTRY, PHARMACEUTICAL; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; TABLETS;

EID: 77952075515     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903110737     Document Type: Article

References (28)

1. Liebau G. Captopril bei Herzinsuffizienz. Klinische Wochenschrift 1982;60:107-113.
2. Khan MA, Sastry SV, Vaithiyalingam SR, Agarwal V, Nazzal S, Reddy IK. Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: Evaluation of main effects of several formulation variables. Int J Pharm 2000;193:147-156.
3. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm 2000;26(9):965-969.
4. Nur AO, Zhang JS. Recent progress in sustained/controlled oral delivery of captopril: An overview. Int J Pharm 2000;194:139-146.
5. Cheng WT, Wang SL, Lin SY. 2007. Solid-state interaction study on the captopril/lubricants systems accelerated by grinding process. J Phys Chem Sol 2008;69(4):1007-1016.
6. Kadin H. Captopril. In: Florey K, editor. Analytical profiles of drug substances. Vol. 11. New York: Academic Press; 1982;108-109.
7. Timmins P, Jackson IM, Wang YJ. Factors affecting captopril stability in aqueous solution. Int J Pharm 1982;11(4):329-336.
8. Seta Y, Higuchi F, Otsuka T, Kawahara Y, Nishimura K, Okada R, Koike H. Preparation and pharmacological evaluation of captopril sustained-release dosage forms using oily semisolid matrix. Int J Pharm 1988;41(3):255-262. (Pubitemid 18034879)
9. Rajinikanth PS, Mishra B. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. Pylori. J Control Release 2008;125:33-41.
10. Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. Oral sustained delivery of atenolol from floating matrix tablets. Formulation and in vitro evaluation. Drug Dev Ind Pharm 2005;31:367-374.
11. Dave BS, Amin AF, Patel MM. Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation. AAPS PharmSciTech 2004;5(2) Art. 34 (http://www.aapspharmscitech.org).
12. Talukder R, Fassihi R. Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm 2004;30(10):1019-1028.
13. Sriamornsak P. Tirawong N, Korkerd K. Swelling, erosion and release behaviour of alginate-based matrix tablets. Eur J Pharm Biopharm 2007;66:435-450. (Pubitemid 46756227)
14. Cedillo-Ramírez E, Hernández-León A, Villafuerte-Robles L. Efect of added Pharmatose DCL11 on the sustained-release of metronidazole from Methocel K4M and Carbopol 971P NF floating matrices. Drug Dev Ind Pharm 2006;32:955-965.
15. Gutiérrez-Sánchez PE, Hernández-León A, Villafuerte-Robles L. Effect of sodium bicarbonate on the properties of metronidazole floating tablets made of Methocel K4M and Carbopol 971P NF. Drug Dev Ind Pharm 2008;34(2):171-180.
16. Grassetti D, Murray J. Determination of sulfhydryl groups with 2, 2'-or 4, 4'-dithiodipyridine. Arch Biochem Biophys 1967;119:41-49.
17. Sigma-Aldrich, Product information. 2008. Captopril. Product number: C4042. Accessed 1 February 2008 from the website: http://www.sigmaaldrich.com/ sigma-aldrich/product-information sheet/c4042pispdf.
18. Sriamornsak P, Tirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. Swelling and erosion of pectin matrix tablets and their impact on drug release behaviour. Eur J Pharm Sci 2007;67:211-219.
19. Bettini R, Castellani PL, Santi P, Massimo G, Peppas NA, Colombo P. Translocation of solid particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate. J Control Release 2001;70:383-391.
20. Jamzad S, Tutunji L, Fassihi R. Analysis of macromolecular changes and drug release from hydrophilic matrix systems. Int J Pharm 2005;292:75-85.
21. Escudero JJ, Ferrero C, Jiménez-Castellanos MR. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: Effect of HPMC of different viscosity grades. Int J Pharm 2008;351:61-73.
22. Cárdenas RH. las ciencias farmacéuticas. Algunos aspectos de actualidad. Universidad Autónoma Metropolitana, México. 2003;147-149.
23. Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxicillin trihydrate. Int J Pharm 1992;86:79-88.
24. Espinoza R, Hong E, Villafuerte L. Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. Int J Pharm 2000;201:165-173.
25. Martínez-González I, Villafuerte-Robles L. Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process. Int J Pharm 2003;257:253-264.
26. Jiménez-Martínez I, Quirino-Barreda T, Villafuerte-Robles L. Sustained delivery of captopril from floating matrix tablets. Int J Pharm 2008;362(1-2): 37-43.
27. López Solis J, Villafuerte Robles L. Effect of disintegrants with different hygroscopicity on dissolution of norfloxacin/Pharmatose DCL 11 tablets. Int J Pharm 2001;216(1-2): 127-135.
28. Martin A, Swarbrick J, Cammarata A. Physical pharmacy. Physical chemical principles in the pharmaceutical sciences. 3rd ed. Philadelphia, USA: Lea & Febiger; 1983:222-223.